Article abstract-Single, small, enhancing lesions that often resolve spontaneously are frequent findings on CTs of Indian patients with seizures. Based on ELISA and biopsy data, the majority of these lesions are probably cysticercosis. To determine if these patients should be treated with albendazole, we performed a double-blind, randomized, placebo-controlled study involving 75 patients with seizures and the appropriate CT abnormality without neurologic abnormality on examination. Patients were randomized to albendazole (15 mgkg/d) and placebo for 1 week, and we obtained serial CTs at the end of 1 week, 1 month, and 3 months. All patients completed a 3-month follow-up and none had systemic evidence of tuberculosis or cysticercosis. The lesions varied in size from 3 mm to 2.1 cm, with an average size of 1.18 cm. Serum ELISA for cysticercosis was positive in 30 and CSF ELISA was positive in 20 of 45 patients. Forty patients received albendazole and 35 received placebo. At the end of 3 months, a total of 68 patients showed resolution. Thirty-five of 40 patients who received albendazole showed resolution, as opposed to 33 of 35 patients on placebo. We conclude that albendazole therapy was not beneficial. Single, small, enhancing lesion (SSEL) on CT of the head is a common finding in epilepsy patients in India. Goulatia et all convincingly demonstrated t h a t the lesions resolved when seizures were controlled with anticonvulsants. Etiologic possibilities considered include tuberculosis, focal encephalitis, microabscess, and cyst i c e r c o~i s .~,~ Ahuja e t a14 detected antibodies against cysticercosis in 12 of 38 patients studied. On stereotaxic biopsy, Chandy et a15 demonstrated cysticercosis in 12 of 15 patients, and the current belief is that the majority of these lesions are cysticer~osis.~-~ Spontaneous resolution of SSEL led some authors t o initially dismiss cysticercosis as the etiology,6 but spontaneous resolution was taken into account by Mitchell and Crawford7 while making a presumptive diagnosis of cysticercosis in children with SSEL. All of these patients were treated with anticonvulsants alone. Mitchell and Crawford7 proposed that these lesions be classified as "acute lesions."
M.V. Padma, DM; M. Behari, DM; N.K. Misra, MD; and G.K. Ahuja, FRCP Single, small, enhancing lesion (SSEL) on CT of the head is a common finding in epilepsy patients in India. Goulatia et all convincingly demonstrated t h a t the lesions resolved when seizures were controlled with anticonvulsants. Etiologic possibilities considered include tuberculosis, focal encephalitis, microabscess, and cyst i c e r c o~i s .~,~ Ahuja e t a14 detected antibodies against cysticercosis in 12 of 38 patients studied. On stereotaxic biopsy, Chandy et a15 demonstrated cysticercosis in 12 of 15 patients, and the current belief is that the majority of these lesions are cysticer~osis.~-~ Spontaneous resolution of SSEL led some authors t o initially dismiss cysticercosis as the etiology,6 but spontaneous resolution was taken into account by Mitchell and Crawford7 while making a presumptive diagnosis of cysticercosis in children with SSEL. All of these patients were treated with anticonvulsants alone. Mitchell and Crawford7 proposed that these lesions be classified as "acute lesions."
It is not known whether cysticidal drugs hasten the resolution of these lesions. Rawlings et a18 have suggested that empiric therapy with praziquantel be used t o hasten the resolution of SSEL. Using this approach, they documented the management of two patients with SSEL, and in both patients the lesions resolved in 2 to 4 weeks' time. Rajshekharg treated 11 patients with albendazole f o r 2 weeks. F o u r p a t i e n t s showed response to therapy; the lesions either resolved completely o r showed significant reduction in size. Because spontaneous resolution is common, it is difficult to say if the resolution was spontaneous o r in response to albendazole.
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Furthermore, since it was an open study, there were no controls. The author himself states that natural involution of the cyst cannot be excluded.
Since albendazole is an effective treatment of cerebral cysticercosis, we carried out a doubleblind, randomized, placebo-controlled study to determine whether it aids in the resolution of SSEL.
M e t h o d s . Seventy-five patients with epilepsy who showed SSELs on contrast-enhanced CTs of the head and demonstrated no neurologic deficit on examination were enrolled. History regarding the type and frequency of seizures, presence of Todd's palsy, headache, and any other neurologic symptom was recorded. Complete clinical assessment was made a t the time of enrollment and a t each follow-up. A careful search was made for subcutaneous nodules. Hemogram, liver and renal function tests, and chest skiagrams were done in all patients. CSF analysis was done in 50 patients. IgM antibodies against cysticercosis and tubercular antigens were measured by ELISA in both serum and CSF in 45 patients. P a t i e n t s were randomly allocated to placebo or albendazole therapy. Albendazole was given in t h e dose of 15 mgkgld for 7 days, in three divided doses. Anticonvulsant medication was continued unchanged. Contrast-enhanced CT of t h e head was done at t h e s t a r t a n d completion of t r e a t m e n t a n d at 1 and 3 months after t h e initiation of treatment. CTs were assessed by a neuroradiologist (N.K.M.) who was not aware of the treatment received by the patient. The assessment was done for the site and size of the lesion and the extent of edema. Any change in the above variables was noted. Total resolution meant that the lesion was no longer discernible on contrast-enhanced CT o r t h a t a punctate calcification was seen a s a residue. When the size of the enhancing lesion or surrounding edema was reduced by 50% or more, it was graded as partial resolution. Statistical analysis of the results was done using Wilcoxon's rank sum test.
8(4)
Results. Seventy-five patients ( 5 2 males and 23 females) with a mean age of 21.8 years (range, 3.5 t o 50) were included in the study. The mean duration of epilepsy was 11.4 months (range, 1 day to 6 years). Fifty-eight patients had partial seizures and 1 7 had generalized tonic-clonic seizures. Neurologic examination was normal in all. None had systemic evidence of tuberculosis o r subcutaneous nodules. The CT lesion was frontal in 48 patients, parietal in 22, occipital in four, and temporal in one. The size of the lesion varied from 3 mm to 2.1 cm, with a mean size of 1.18 cm. The perilesional edema varied from 8 mm to 5 cm, with a mean of 2 cm. Serum ELISA for cysticercosis was positive in 30 of 45 patients. Twenty of these 30 patients showed positive response in CSF as well. Forty patients were randomized to albendazole a n d 35 received placebo.
Resolution of the CT lesion was seen a t the 1-week interval in 27 patients, a t the 1-month interval in 54 patients, and at the 3-month interval in 68 patients. Thirty-five of 40 patients on albendazole ( p < 0.01) and 33 of 35 patients on placebo ( p < 0.01) showed resolution at the end of 3 months. Applying Wilcoxon's rank sum test, there was no statistically significant difference seen in the results obtained between the two groups. Five patients showed no change in the CT lesions a t t h e end of 3 months, a n d two patients (one who received albendazole and one who received placebo) showed an increase in size and edema. The results are summarized in the table.
